What is Insulin Access Program?

The DOH Insulin Access Program is a program under the Medicine Access Program (MAP) of the Department of Health (DOH) through the National Center for Pharmaceutical Access and Management (NCPAM) provides access to medicines for diabetic patients and is in line with Millennium Development Goal No. 8 aims to develop global partnership for development, where partner pharmaceutical companies participate by providing access to affordable Insulin products through the consignment system., implementation of which was started in 2009.